Inactive Instrument

Sector ratings Mount Magnet South Ltd Australian S.E.

Stocks

End-of-day quote Australian S.E.
- ^AUD	-

09-25	Incannex Healthcare Inc. Reports Earnings Results for the Full Year Ended June 30, 2026	CI
09-09	Incannex Healthcare Commences Patient Dosing in DReAMzz Phase 2 Study Of IHL-42X and Reports Clinical Progress	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility
WUXI APPTEC CO., LTD.	72.26B		AAA
ARGENX SE	60.24B		A
WUXI BIOLOGICS (CAYMAN) INC.	27.73B		AAA
INSMED INCORPORATED	25.74B	-	BBB	-		-
BIONTECH SE	24.75B	-	-	-		-
GENMAB A/S	20.74B		A
PHARMAESSENTIA CORPORATION	15.06B		AA
EXELIXIS, INC.	14.42B		BB
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	14.23B		AA
SUMMIT THERAPEUTICS INC.	12.45B	-	-	-		-
MADRIGAL PHARMACEUTICALS, INC.	11.93B	-	B	-		-
AKESO, INC.	10.99B		B			-
ARROWHEAD PHARMACEUTICALS, INC.	9.31B	-	BB	-		-
IMMUNITYBIO, INC.	8.95B	-	CCC	-		-
CYTOKINETICS, INCORPORATED	8.99B	-	AA	-		-
VAXCYTE, INC.	8.36B	-	BBB	-		-
REMEGEN CO., LTD.	8.06B		-
SPYRE THERAPEUTICS, INC.	7.56B	-	BB	-	-	-
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.	6.99B	-	BB	-		-	-
Average	19.41B		A
Weighted average by Cap.			A